{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:57:14Z","timestamp":1790211434142,"version":"4.1.0"},"reference-count":100,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abbot Laboratories","award":["CE1784A1-53DB-4FFE-8505-470314A5D17A"],"award-info":[{"award-number":["CE1784A1-53DB-4FFE-8505-470314A5D17A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Migraine is markedly more prevalent among individuals with bipolar disorder (BD) than in the general population. The two disorders share overlapping pathophysiological mechanisms, including neuroinflammation, oxidative stress, and genetic vulnerability. However, the potential bidirectional efficacy of pharmacological agents approved for one condition on the other remains unclear. This study aimed to evaluate cross-disorder pharmacological efficacy between migraine and bipolar disorder. Methods: We systematically searched Medline and the Cochrane Central Register of Controlled Trials (PROSPERO registration: CRD420251130780) for randomized controlled trials (RCTs) assessing (1) concurrent treatment effects in comorbid BD\u2013migraine samples, (2) efficacy of migraine treatments in BD, or (3) efficacy of BD treatments in migraine. Searches included guideline-recommended drugs for either disorder, without language or date restrictions. Results: A total of 32 RCTs met the inclusion criteria. Fifteen studies evaluated migraine drugs in BD, and sixteen evaluated BD drugs in migraine. No RCTs were identified that simultaneously assessed both conditions within the same sample. Valproate was the only agent demonstrating consistent, replicated efficacy in both conditions, supporting true cross-disorder benefit. Haloperidol and chlorpromazine showed limited evidence for acute anti-migraine efficacy, based solely on placebo-controlled studies, whereas all other guideline-recommended BD drugs lacked evidence of benefit for migraine. Conversely, topiramate, while effective for migraine, was inferior to valproate in BD outcomes, and lamotrigine was effective for BD only when compared with placebo. Conclusions: Valproate remains the sole pharmacological agent with robust evidence of bidirectional efficacy in migraine and BD. Most other guideline-recommended medications show disorder-specific effects, highlighting the need for integrative trials addressing pharmacological overlap in comorbid migraine\u2013BD samples.<\/jats:p>","DOI":"10.3390\/ph19060848","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:08:02Z","timestamp":1780535282000},"page":"848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Overlap Between Bipolar Disorder and Migraine: A Systematic Review of Pharmacological Trials"],"prefix":"10.3390","volume":"19","author":[{"given":"Michel","family":"Haddad","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Brazilian Clinical Research Institute, S\u00e3o Paulo 01404-000, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo 04021-001, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-5999","authenticated-orcid":false,"given":"Luiz Henrique Junqueira","family":"Dieckmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Brazilian Clinical Research Institute, S\u00e3o Paulo 01404-000, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo 04021-001, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-2670","authenticated-orcid":false,"given":"Naielly","family":"Rodrigues da Silva","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Brazilian Clinical Research Institute, S\u00e3o Paulo 01404-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5797-2252","authenticated-orcid":false,"given":"Paula","family":"Dieckmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo 04021-001, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-1695","authenticated-orcid":false,"given":"Thiago Wendt","family":"Viola","sequence":"additional","affiliation":[{"name":"School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90619-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-0112","authenticated-orcid":false,"given":"Jair de Jesus","family":"Mari","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo 04021-001, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1526-4610.2003.03184.x","article-title":"Prevalence, clinical correlates, and treatment of migraine in bipolar disorder","volume":"43","author":"Low","year":"2003","journal-title":"Headache"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2015.02.032","article-title":"A meta-analysis investigating the prevalence and moderators of migraines among people with bipolar disorder","volume":"178","author":"Fornaro","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jad.2025.03.045","article-title":"Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohort","volume":"379","author":"Samalin","year":"2025","journal-title":"J. Affect. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2021.08.026","article-title":"Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity","volume":"295","author":"Blom","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10072-018-3356-8","article-title":"Bipolar disorder and chronic migraine: An open problem","volume":"39","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1566524016666160126144440","article-title":"The Comorbidity of Bipolar Disorder and Migraine: The Role of Inflammation and Oxidative and Nitrosative Stress","volume":"16","author":"Passos","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMra1915327","article-title":"Migraine","volume":"383","author":"Ashina","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/head.12505_2","article-title":"Episodic and chronic migraine headache: Breaking down barriers to optimal treatment and prevention","volume":"55","author":"Lipton","year":"2015","journal-title":"Headache"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar Disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and Treatment of Bipolar Disorder: A Review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"Jama"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2009.06.014","article-title":"A genome-wide linkage study of bipolar disorder and co-morbid migraine: Replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11","volume":"122","author":"Oedegaard","year":"2010","journal-title":"J. Affect. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Duan, J., Yang, R., Lu, W., Zhao, L., Hu, S., and Hu, C. (2020). Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.560138"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/brain\/awad326","article-title":"Increased presynaptic excitability in a migraine with aura mutation","volume":"147","author":"Suryavanshi","year":"2024","journal-title":"Brain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106030","DOI":"10.1016\/j.neubiorev.2025.106030","article-title":"Decoding neural circuit dysregulation in bipolar disorder: Toward an advanced paradigm for multidimensional cognitive, emotional, and psychomotor treatment","volume":"169","author":"Steardo","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1038\/s41598-022-10883-9","article-title":"Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine","volume":"12","author":"Park","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104906","DOI":"10.1016\/j.neubiorev.2022.104906","article-title":"The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder","volume":"142","author":"Guglielmo","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroscience.2022.02.010","article-title":"Decreased Brain GABA Levels in Patients with Migraine Without Aura: An Exploratory Proton Magnetic Resonance Spectroscopy Study","volume":"488","author":"Wu","year":"2022","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bdi.12074","article-title":"Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder","volume":"15","author":"Brady","year":"2013","journal-title":"Bipolar Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e142203","DOI":"10.1172\/JCI142203","article-title":"Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels","volume":"131","author":"Chever","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.1424958112","article-title":"Rare variants in neuronal excitability genes influence risk for bipolar disorder","volume":"112","author":"Ament","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1007\/s12325-023-02586-y","article-title":"Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations","volume":"40","author":"Pearl","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bph.12534","article-title":"Properties of human brain sodium channel \u03b1-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine","volume":"171","author":"Qiao","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112021","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: A new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.seizure.2022.03.024","article-title":"Molecular mechanisms of topiramate and its clinical value in epilepsy","volume":"98","author":"Bai","year":"2022","journal-title":"Seizure"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jphs.13116SC","article-title":"Effect of lamotrigine on Na(v)1.4 voltage-gated sodium channels","volume":"123","author":"Nakatani","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"ref_27","first-page":"344","article-title":"The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence","volume":"21","author":"Keramatian","year":"2023","journal-title":"Focus (Am. Psychiatr. Publ.)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3331024241269735","DOI":"10.1177\/03331024241269735","article-title":"International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine","volume":"44","author":"Puledda","year":"2024","journal-title":"Cephalalgia"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_30","unstructured":"American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [4th ed.]."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"American Psychiatric Publishing, Inc. (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM, American Psychiatric Publishing, Inc.. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_32","unstructured":"World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, World Health Organization."},{"key":"ref_33","unstructured":"World Health Organization (2018). ICD-11 International Classification of Diseases for Mortality and Morbidity Statistics, World Health Organization."},{"key":"ref_34","unstructured":"International Headache Society (2004). The International Classification of Headache Disorders: 2nd edition. Cephalalgia, 24, 9\u2013160."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_37","first-page":"e7","article-title":"Continuous and pulsed radiofrequency: An update","volume":"41","year":"2016","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/YIC.0000000000000394","article-title":"Oxcarbazepine versus sodium valproate in treatment of acute mania: A double-blind randomized clinical trial","volume":"37","author":"Talaei","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0028-1128115","article-title":"Translation of randomised controlled trial findings into clinical practice: Comparison of olanzapine and valproate in the EMBLEM study","volume":"42","author":"Novick","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v64n0310","article-title":"Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: Health-related quality of life and medical cost outcomes","volume":"64","author":"Revicki","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: A placebo-controlled study","volume":"85","author":"Davis","year":"2005","journal-title":"J. Affect. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.01.002","article-title":"Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: Results of a naturalistic clinical trial","volume":"86","author":"Revicki","year":"2005","journal-title":"J. Affect. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"ref_44","first-page":"6","article-title":"Double-blind, randomized, clinical trial of topiramate versus sodium valproate for the treatment of bipolar disorder in adolescents","volume":"25","author":"Hebrani","year":"2009","journal-title":"Pak. J. Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4088\/JCP.v68n1203","article-title":"Divalproex in the treatment of acute bipolar depression: A preliminary double-blind, randomized, placebo-controlled pilot study","volume":"68","author":"Ghaemi","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cts.12407","article-title":"Endoxifen, a New Treatment Option for Mania: A Double-Blind, Active-Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen","volume":"9","author":"Ahmad","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YIC.0b013e328333ac1b","article-title":"Efficacy of valproate versus lithium in mania or mixed mania: A randomized, open 12-week trial","volume":"25","author":"Bowden","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4088\/JCP.09m05570gre","article-title":"Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: A double-blind, randomized, placebo-controlled trial","volume":"72","author":"Muzina","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder","volume":"44","author":"Findling","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group","volume":"61","author":"Calabrese","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"ref_53","first-page":"150","article-title":"Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder","volume":"38","author":"Foroughipour","year":"2013","journal-title":"Iran. J. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.15441\/ceem.16.199","article-title":"Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: A double-blind randomized clinical trial","volume":"4","author":"Karimi","year":"2017","journal-title":"Clin. Exp. Emerg. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mazaheri, S., Poorolajal, J., Hosseinzadeh, A., and Fazlian, M.M. (2015). Effect of intravenous sodium valproate vs. dexamethasone on acute migraine headache: A double blind randomized clinical trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120229"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejpn.2005.05.004","article-title":"Sodium Valproate versus Propranolol in paediatric migraine prophylaxis","volume":"9","author":"Ashrafi","year":"2005","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_57","first-page":"105","article-title":"Comparing Prophylactic Effect of Levetiracetam, Sodium Valproate, and Propranolol in Pediatric Migraine: A Randomized Clinical Trial","volume":"17","author":"Fayyazi","year":"2023","journal-title":"Iran. J. Child Neurol."},{"key":"ref_58","first-page":"633","article-title":"Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack","volume":"53","author":"Ghaderibarmi","year":"2015","journal-title":"Acta Med. Iran."},{"key":"ref_59","first-page":"171","article-title":"Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial","volume":"39","author":"Rahimdel","year":"2014","journal-title":"Iran. J. Med. Sci."},{"key":"ref_60","first-page":"385","article-title":"Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial","volume":"35","author":"Sharafkhah","year":"2017","journal-title":"Restor. Neurol. Neurosci."},{"key":"ref_61","first-page":"121","article-title":"Comparing Pregabalin and Sodium Valproate in Pediatric Migraine Prophylaxis: A Randomized Clinical Trial","volume":"17","author":"Jafari","year":"2023","journal-title":"Iran. J. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajem.2022.02.046","article-title":"Intravenous ibuprofen versus sodium valproate in acute migraine attacks in the emergency department: A randomized clinical trial","volume":"55","author":"Dogruyol","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e23768","DOI":"10.5812\/ircmj.23768","article-title":"Comparing Zonisamide with Sodium Valproate in the Management of Migraine Headaches: Double-Blind Randomized Clinical Trial of Efficacy and Safety","volume":"18","author":"Assarzadegan","year":"2016","journal-title":"Iran. Red Crescent Med. J."},{"key":"ref_64","first-page":"8","article-title":"Investigating the effectiveness of Sodae herbal capsule on migraine headaches and comparing it with sodium valproate","volume":"81","author":"Afshari","year":"2024","journal-title":"Tehran Univ. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0736-4679(02)00502-4","article-title":"Intravenous chlorpromazine in the emergency department treatment of migraines: A randomized controlled trial","volume":"23","author":"Bigal","year":"2002","journal-title":"J. Emerg. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10072-019-03766-x","article-title":"Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, and chlorpromazine for pain relief and prevention of recurrence in the migraine headache: A prospective double-blind randomized clinical trial","volume":"40","author":"Khazaei","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jemermed.2020.04.018","article-title":"Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial","volume":"59","author":"McCoy","year":"2020","journal-title":"J. Emerg. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","article-title":"Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial","volume":"24","author":"Sarchielli","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_69","first-page":"1344","article-title":"Effectiveness of Vitamin B2 versus Sodium Valproate in Migraine Prophylaxis: A randomized clinical trial","volume":"7","author":"Rahimdel","year":"2015","journal-title":"Electron Physician"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000543555","article-title":"Advancements in Valproate Therapy for Seizures, Migraines, and Bipolar Disorders","volume":"34","author":"Bairy","year":"2025","journal-title":"Med. Princ. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.9758\/cpn.2022.20.1.61","article-title":"Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder","volume":"20","author":"Lin","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e087999","DOI":"10.1136\/bmjopen-2024-087999","article-title":"The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: An overview of systematic reviews with meta-analyses","volume":"14","author":"Mari","year":"2024","journal-title":"BMJ Open"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/HRP.0000000000000292","article-title":"Long-Term Treatment of Bipolar Disorder with Valproate: Updated Systematic Review and Meta-analyses","volume":"29","author":"Yee","year":"2021","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_74","first-page":"Cd003384","article-title":"Topiramate for acute affective episodes in bipolar disorder in adults","volume":"9","author":"Pigott","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1034\/j.1399-5618.2001.30501.x","article-title":"The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder","volume":"3","author":"Chengappa","year":"2001","journal-title":"Bipolar Disord."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004714-200212000-00010","article-title":"Review of the use of topiramate for treatment of bipolar disorders","volume":"22","author":"Suppes","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1345\/aph.1A398","article-title":"The use of topiramate in mood stabilization","volume":"36","author":"Maidment","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e945464","DOI":"10.12659\/MSM.945464","article-title":"Lamotrigine: A Safe and Effective Mood Stabilizer for Bipolar Disorder in Reproductive-Age Adults","volume":"30","author":"Cyrkler","year":"2024","journal-title":"Med. Sci. Monit."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Prabhavalkar, K.S., Poovanpallil, N.B., and Bhatt, L.K. (2015). Management of bipolar depression with lamotrigine: An antiepileptic mood stabilizer. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00242"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","article-title":"The comparative effectiveness of migraine preventive drugs: A systematic review and network meta-analysis","volume":"24","author":"Lampl","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1526-4610.2001.01142.x","article-title":"Valproic acid is effective in migraine prophylaxis at low serum levels: A prospective open-label study","volume":"41","author":"Kinze","year":"2001","journal-title":"Headache"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/ANNALS-24-01052","article-title":"Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline from the American College of Physicians","volume":"178","author":"Qaseem","year":"2025","journal-title":"Ann. Intern. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.21037\/tp-24-279","article-title":"Efficacy of prophylactic sodium valproate in pediatric migraines: A systematic review of randomized clinical studies","volume":"13","author":"Askar","year":"2024","journal-title":"Transl. Pediatr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/ejn.16106","article-title":"D2 dopamine receptor-mediated mechanisms of dopaminergic system modulation in in vivo and in vitro experimental models of migraine","volume":"59","author":"Torun","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/head.12835","article-title":"Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies","volume":"56","author":"Orr","year":"2016","journal-title":"Headache"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2016.12.051","article-title":"Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na(v)1.7","volume":"639","author":"Lee","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Spekker, E., Nagy-Gr\u00f3cz, G., and V\u00e9csei, L. (2023). Ion Channel Disturbances in Migraine Headache: Exploring the Potential Role of the Kynurenine System in the Context of the Trigeminovascular System. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316574"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(05)66786-4","article-title":"Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine","volume":"366","author":"Dichgans","year":"2005","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"104514","DOI":"10.1016\/j.jpain.2024.03.010","article-title":"Voltage-gated Calcium Channels as Potential Therapeutic Targets in Migraine","volume":"25","author":"Chichorro","year":"2024","journal-title":"J. Pain"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"16401","DOI":"10.1007\/s00210-025-04422-2","article-title":"Efficacy and safety of calcium channel blockers in migraine management; a systematic review","volume":"398","author":"Ghiami","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Imbrici, P., Camerino, D.C., and Tricarico, D. (2013). Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front. Genet., 4.","DOI":"10.3389\/fgene.2013.00076"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1007\/s10072-025-08372-8","article-title":"Anti-CGRP monoclonal antibodies, migraine and mood disorders: An observational study","volume":"46","author":"Bolchini","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3331024231222923","DOI":"10.1177\/03331024231222923","article-title":"Improvement of migraine depressive symptoms is not related to headache frequency: Exploring the impact of anti-CGRP therapies","volume":"44","author":"Gallardo","year":"2024","journal-title":"Cephalalgia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/jamaneurol.2025.0806","article-title":"Fremanezumab for the Treatment of Patients with Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial","volume":"82","author":"Lipton","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.2005.00522.x","article-title":"Valproate in bipolar disorder: 2000 onwards","volume":"111","author":"Bowden","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jad.2015.01.024","article-title":"Rapid cycling as a feature of bipolar disorder and comorbid migraine","volume":"175","author":"Forty","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2014.09.020","article-title":"Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review","volume":"56","author":"Fornaro","year":"2015","journal-title":"Compr. Psychiatry"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:10:09Z","timestamp":1780535409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":100,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ph19060848"],"URL":"https:\/\/doi.org\/10.3390\/ph19060848","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}